Cardiac Effects of Blood Cancers vs Solid Tumors
Author Information
Author(s): Udin Michael H., Sunder Sunitha Shyam, Nepali Sarmila, Kattel Sharma, Abdelradi Amr, Doyle Scott T., Ionita Ciprian N., Liu Qian, Sharma Umesh C.
Primary Institution: Roswell Park Comprehensive Cancer Center
Hypothesis
How do hematological malignancies affect cardiac morphology compared to solid tumors?
Conclusion
Hematological malignancy patients show more cardiac dysfunction and structural changes than those with solid tumors.
Supporting Evidence
- Hematological malignancy patients had lower cardiomyocyte nuclei counts than solid tumor patients.
- HM patients showed higher levels of B-type natriuretic peptide, indicating cardiac stress.
- Collagen fiber alignment was significantly lower in HM patients compared to ST patients.
Takeaway
Patients with blood cancers have more heart problems than those with other types of cancer.
Methodology
The study analyzed cardiac changes in 198 patients with hematological malignancies and 164 patients with solid tumors, comparing demographics, echocardiogram data, and post-mortem findings.
Potential Biases
Treatment variability and lack of longitudinal data may confound results.
Limitations
The study's retrospective nature and reliance on post-mortem evaluations may introduce selection biases and affect data accuracy.
Participant Demographics
Average age was 60, with 134 females and 228 males; most common cancer was acute myeloid leukemia.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website